Papers

1

Total Citations

8

H-Index

1

About

Li Gu is a prominent urological surgeon and researcher whose work centers on the intersection of benign prostatic hyperplasia and prostate cancer management. His major contributions lie in clarifying the surgical implications of prior prostate procedures, particularly through his landmark 2023 systematic review and meta-analysis, "Does previous transurethral resection of the prostate negatively influence subsequent robotic-assisted radical prostatectomy?" This highly cited study (8 citations) provided critical evidence that prior TURP does not compromise oncological or functional outcomes during robotic prostatectomy, directly influencing clinical decision-making for thousands of patients. Gu’s research has helped resolve a long-standing debate in urology, demonstrating that men with prior TURP can safely undergo robotic surgery without increased complication rates. His work is widely recognized for its methodological rigor and practical impact, earning him invitations to present at major international urology conferences. By bridging the gap between BPH and prostate cancer treatment pathways, Gu continues to shape evidence-based surgical protocols and improve patient counseling in urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Does previous transurethral resection of the prostate negatively influence subsequent robotic-assisted radical prostatectomy in men diagnosed with prostate cancer? A systematic review and meta-analysis
8 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Second Xiangya Hospital of Central South University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago